Published in J Hypertens on March 01, 2001
Ageing and vascular ageing. Postgrad Med J (2006) 1.36
Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med (2008) 1.00
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals. Cardiovasc Diabetol (2012) 0.85
Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet (2005) 0.84
The genetic basis for altered blood vessel function in disease: large artery stiffening. Vasc Health Risk Manag (2005) 0.83
Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection? Int J Hypertens (2010) 0.81
Subclinical renal insufficiency range of estimated glomerular filtration rate and microalbuminuria are independently associated with increased arterial stiffness in never treated hypertensives. Korean Circ J (2013) 0.81
Mechanical properties of normal and diseased cerebrovascular system. J Vasc Interv Neurol (2009) 0.80
A review of genetics, arterial stiffness, and blood pressure in African Americans. J Cardiovasc Transl Res (2012) 0.79
Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease. Vasc Health Risk Manag (2008) 0.78
The control of blood pressure might be important in delaying progression of arterial aging in patients with type 2 diabetes mellitus. Clin Interv Aging (2014) 0.75
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension (2001) 11.18
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension (1995) 4.83
Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension (1999) 4.56
Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension (2001) 4.07
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol (2001) 3.38
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension (1997) 3.21
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation (1999) 2.56
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41
Improvement of internal jugular vein cannulation using an ultrasound-guided technique. Intensive Care Med (1997) 2.33
Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Eur Heart J (2002) 2.30
Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension (1998) 2.20
Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol (1980) 2.06
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia (1989) 1.96
Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med (1998) 1.95
Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes (1994) 1.85
Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation (1999) 1.80
Increased systolic pressure in chronic uremia. Role of arterial wave reflections. Hypertension (1992) 1.78
Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis (1995) 1.74
Comparative study of methodologies for pulse wave velocity estimation. J Hum Hypertens (2008) 1.73
Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension (1989) 1.72
Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension (1999) 1.71
Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens (2001) 1.66
TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study. J Hum Hypertens (2007) 1.59
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia (1995) 1.57
Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int (2001) 1.54
Reliability of reported family history of myocardial infarction. BMJ (1993) 1.52
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest (2001) 1.51
New polymorphisms in the interleukin-10 gene--relationships to myocardial infarction. Eur J Clin Invest (2001) 1.50
Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet (1996) 1.50
Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol (2001) 1.47
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46
PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans (2006) 1.44
New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol (2000) 1.42
Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens (1997) 1.41
Distribution of lipid variables in subjects in Belfast, Northern Ireland and Taiyuan, P R China. Atherosclerosis (1993) 1.39
Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med (1994) 1.36
Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol (1994) 1.35
Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol (2000) 1.34
Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation (1999) 1.25
APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol (2006) 1.23
Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med (2001) 1.23
Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study. Atherosclerosis (1999) 1.22
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes (1995) 1.20
Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol (2001) 1.18
Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest (1998) 1.18
Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol (2000) 1.18
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet (2000) 1.18
Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit (2001) 1.18
Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension (1996) 1.17
Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study. J Hypertens (2001) 1.16
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation (1996) 1.16
The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet (1998) 1.15
Pre-existing arterial stiffness can predict hypotension during induction of anaesthesia in the elderly. Br J Anaesth (2010) 1.15
Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation (1996) 1.14
Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens (1998) 1.14
Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol (2000) 1.14
Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am J Epidemiol (1986) 1.14
Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? Am J Epidemiol (1985) 1.13
Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol (1990) 1.13
Opposing effects of ageing on distal and proximal large arteries in hypertensives. J Hypertens Suppl (1992) 1.12
Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass for tissue engineering applications. Biomaterials (2002) 1.12
Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J (1991) 1.12
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.11
Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica (1984) 1.11
Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med (Berl) (2001) 1.11
Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine. Br J Pharmacol (1999) 1.10
Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension (1994) 1.10
The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes (1986) 1.10
Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. Am J Cardiol (1984) 1.09
Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol (1999) 1.09
Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb (1994) 1.08
Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press (1995) 1.08
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet (2004) 1.07
Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis (1986) 1.07
The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. Br J Pharmacol (1983) 1.07
Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol (1998) 1.07
Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol (1997) 1.07
Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol (1994) 1.07